Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics ( SHARE LAI ‐net)’
HIV Medicine · 2024
DOI: 10.1111/hiv.13689 ↗Kurz gefasst
Leserbrief in der Zeitschrift HIV Medicine, 2024. Verfasst von Sanjit Sah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India. Hauptthemen laut MEDLINE: HIV Infections, Rilpivirine, Pyridones, Anti-HIV Agents. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India.
- Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, India.
- Department of Internal Medicine, Rama Medical College Hospital and Research Centre, Hapur, India.
- South Asia Infant Feeding Research Network (SAIFRN), Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.
- School of Applied and Life Sciences, Uttaranchal University, Dehradun, India.
ORCID-Profile: Sanjit Sah, Amogh Verma
Zitieren
APA
Sah, S., Verma, A., Zahiruddin, Q. S., & Rustagi, S. (2024). Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics ( SHARE LAI ‐net)’. HIV Medicine. https://doi.org/10.1111/hiv.13689
Vancouver
Sah S, Verma A, Zahiruddin QS, Rustagi S. Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics ( SHARE LAI ‐net)’. HIV Medicine. 2024. doi:10.1111/hiv.13689
BibTeX
@article{Sah2024,
author = {Sah, Sanjit and Verma, Amogh and Zahiruddin, Quazi Syed and Rustagi, Sarvesh},
title = {Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics ( SHARE LAI ‐net)’},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13689}
}
EUVIMED